Tekrarlayan hemoptizi ile başvuran Takayasu arteritli bir erkek olgu

Muhammet Limon; Semral Gülcemal; Dilek Tezcan; Sema Yılmaz

doi:10.17826/cumj.476319

Olgu Sunumu

A male patient with Takayasu's arteritis presenting with recurrent hemoptysis

Yıl 2019, Cilt: 44 Sayı: 3, 1131 - 1134, 30.09.2019

Muhammet Limon , Semral Gülcemal , Dilek Tezcan , Sema Yılmaz

https://doi.org/10.17826/cumj.476319

Öz

Takayasu’s arteritis is a chronic granulomatous inflammatory large vessel vasculitis of unknown etiology. Takayasu’s arteritis primarily affects the aorta and its primary branches. Women are affected in 80 to 90 percent of cases, with an age of onset that is usually between 10 and 40 years. The onset of clinical symptoms in Takayasu’s arteritis are variably. Symptoms of vascular disease are cyanosis and/or pain in arms or legs, lightheadedness or other symptoms of reduced blood flow, or nonspecific constitutional symptoms. Pulmonary hemorrhage is rare in Takayasu’s arteritis. This case is presented because of the progress of cavitary lesion in the lung due to aspergilloma by immunosuppressive treatment.

Anahtar Kelimeler

Takayasu’s arteritis, hemoptysis, aspergilloma

Kaynakça

1. Sharma BK, Jain S, Kumari S. Systemic manifestations of Takayasu’s arteritis: expanding spectrum. Int J Cardiol 1996;54:149-154
2.Kerr GS. Takayasu’s arteritis. Rheum Dis Clin North Am 1995;21:1041-1058.
3. Jain S, Kumari S, Ganguly NK, et al. Current status of Takayasu’s arteritis in India. Int J Cardiol 1996;54:111-116.
4.Manganelli P, Fietta P, Carotti M, et al. F. Clin Exp Rheumatol. Respiratory system involvement in systemic vasculitides. .Clin Exp Rheumatol. 2006;24:48-59.
5.Nakabayashi K, Kurata N, Nangi N, et al. Pulmonary artery involvement as first manifestation in three cases of Takayasu arteritis. Int J Cardiol 1996; 54:177-83
6.Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994; 120:919.
7.Michel BA, Arend WP, Hunder GG. Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. J Rheumatol. 1996;23:106-11.
8.Neidhart B, Kosek R, Bachmann LM, et al. Exertional dyspnea as initial manifestation of Takayasu's arteritis--a case report and literature review. BMC Pulm Med.2001;1:3.
9.Koyabu S, Isaka N, Yada T, et al. Severe respiratory failure caused by recurrent pulmonary hemorrhage in Takayasu's arteritis. Chest.1993;104:1905-6.
10.Savage BJ, Gupta RK, Angle J, et al.Takayasu arteritis presenting as a pulmonary-renal syndrome.2003;325:275-81.
11.Carol A Langford. Takayasu’s arteritis. In: Marc C. Hochberg, Alan J.Silman, Josef S.Smolen, Michael E.Weinblatt, Michael H.Weisman(eds). Rheumatology. Fourth ed. Spain: Mosby Elsevier;2008:1553-1559.
12.Edwards KK, Lindsley HB, Lai CW, et al. Takayasu arteritis presenting as retinal and vertebrobasilar ischemia. J Rheumatol. 1989;16:1000-2.
13.Cash JM, Engelbrecht JA. Takayasu's arteritis in western South Dakota. S D J Med. 1990;43:5-9.
14.Rodríguez-Hurtado FJ, Sabio JM, Lucena J, et al. Ocular involvement in Takayasu's arteritis: response to cyclophosphamide therapy. Eur J Med Res. 2002;7:128-30.
15.Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50:2296-304.
16.Comarmond C, Plaisier E, Dahan K, et al. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.Autoimmun Rev. 2012;11:678-84
17. Nishimoto N, Nakahara H, Yoshio-Hoshino N, et al..Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum. 2008;58:1197-200
18.Salvarani C, Magnani L, Catanoso M.Tosilizumab:a novel therapy for patients with large-vessel vasculitis.Rheumatology.2012;51:151-6